Client News

Home/Client News
Client News 2018-08-28T11:24:45+00:00
December 18, 2017
STRATA Skin Sciences Announces Exploration of Strategic Alternatives
HORSHAM, Pa., Dec. 18, 2017 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (SSKN) (“STRATA”) a medical technology company in Dermatology and Plastic Surgery dedicated to ...
December 18, 2017
Catalyst Biosciences Announces Acceleration of Phase 1/2 Trial of CB 2679d/ISU304 in Individuals with Hemophilia B
SOUTH SAN FRANCISCO, Calif., Dec. 18, 2017 (GLOBE NEWSWIRE) -- Catalyst Biosciences, Inc. (CBIO), today announces that the Korean Ministry of Food and Drug Safety ...
December 18, 2017
Opiant Pharmaceuticals Announces Publication of New Pre-Clinical Data Supporting Potential of OPNT005 as a Heroin Vaccine
SANTA MONICA, Calif., Dec. 18, 2017 (GLOBE NEWSWIRE) -- Opiant Pharmaceuticals, Inc. (“Opiant”) (OPNT), a specialty pharmaceutical company developing pharmacological treatments for addictions, today reports ...
December 18, 2017
New Biomarker Data Supports Direct Link between VB-111’s Dual Mechanism of Action and its Clinical Effect on Overall Survival and Progression Free Survival in Recurrent Glioblastoma Multiforme Patients
TEL AVIV, Israel, Dec. 18, 2017 (GLOBE NEWSWIRE) -- VBL Therapeutics (VBLT), announced new biomarker data supporting the direct link between lead asset VB-111’s dual ...
December 18, 2017
La Jolla Pharmaceutical Company Announces Initiation of Multicenter, Randomized, Phase 2 Clinical Study of LJPC‑401 in Patients with Hereditary Hemochromatosis
SAN DIEGO, Dec. 18, 2017 (GLOBE NEWSWIRE) -- La Jolla Pharmaceutical Company(LJPC) (the Company or La Jolla) today announced the initiation of LJ401-HH01, a Phase ...
December 18, 2017
Prometic's Plasminogen (Ryplazim™) granted orphan drug designation for the treatment of idiopathic pulmonary fibrosis (IPF)
LAVAL, QC, Dec. 18, 2017 /CNW Telbec/ - Prometic Life Sciences Inc. (PLI.TO) (PFSCF) (Prometic) announced today that an orphan drug designation status has been ...
December 14, 2017
OSE Immunotherapeutics Receives a Grant From French Government Program “Fonds Unique Interministériel” to Explore New Cytotoxic Antibodies
NANTES, France, Dec. 14, 2017 (GLOBE NEWSWIRE) -- OSE Immunotherapeutics(ISIN:FR0012127173) (Mnémo:OSE), today announces that the Company will receive a €398,000 grant from the “Fonds Unique Interministériel” ...
December 14, 2017
Advaxis to Host Business Update and Fiscal Year End 2017 Financial Results Conference Call on December 21, 2017
PRINCETON, N.J.--(BUSINESS WIRE)--Advaxis, Inc. (ADXS), a late-stage biotechnology company focused on the discovery, development and commercialization of immunotherapy products, announces that the Company will release financial ...
December 14, 2017
Catalyst Biosciences Announces Appointment of Edward Williams to its Board of Directors
SOUTH SAN FRANCISCO, Calif., Dec. 14, 2017 (GLOBE NEWSWIRE) -- Catalyst Biosciences, Inc. (CBIO), a clinical-stage biopharmaceutical company focused on developing novel medicines to address ...
December 14, 2017
Rockwell Medical Signs Exclusive License Agreement with Comercializadora BioRenal SpA to Commercialize Triferic® in Chile
WIXOM, Mich., Dec. 14, 2017 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. (RMTI), announced today that it has signed an exclusive license and manufacturing supply agreement ...
December 14, 2017
Kitov Announces Consensi™ as Brand Name for KIT-302
TEL AVIV, Israel, December 14, 2017 /PRNewswire/ -- Kitov Pharmaceuticals (KTOV) (KTOV.TA), an innovative biopharmaceutical company, announced today that the U.S. Food & Drug Administration (FDA) has granted ...
December 13, 2017
SHINE to Participate in Corporate Access Event in San Francisco, January 8 - 10, 2018
JANESVILLE, Wis., Dec. 13, 2017 (GLOBE NEWSWIRE) -- SHINE Medical Technologies, Inc. (SHINE), a Wisconsin-based company dedicated to being the world leader in the safe, ...
December 13, 2017
Women In Bio Holds First Annual Boardroom Ready Reception & Retreat for 2016/2017 Alumni in New York
BOSTON, Dec. 13, 2017 (GLOBE NEWSWIRE) -- Women In Bio (WIB) an organization of professionals committed to promoting careers, leadership, and entrepreneurship of women in the life ...
December 13, 2017
Windtree Therapeutics to Participate in Corporate Access Event in San Francisco, January 8 - 10, 2018
WARRINGTON, Pa., Dec. 12, 2017 /PRNewswire/ -- Windtree Therapeutics, Inc. (WINT), a biotechnology company focused on developing aerosolized KL4 surfactant therapies for respiratory diseases, today announced that its ...
December 13, 2017
MiMedx Forecasts 2018 Revenue To Be In The Range Of $383 Million To $387 Million
MARIETTA, Ga., Dec. 13, 2017 /PRNewswire/ -- MiMedx Group, Inc. (MDXG), the leading biopharmaceutical company developing and marketing regenerative and therapeutic biologics utilizing human placental tissue allografts with ...
December 13, 2017
DURECT Announces NDA Acceptance of Indivior's RBP-7000 Risperidone Monthly Depot
CUPERTINO, Calif., Dec. 13, 2017 /PRNewswire/ -- DURECT Corporation (DRRX) today announced that Indivior PLC (INDV.L) has reported that the U.S. Food and Drug Administration (FDA) has accepted ...
December 13, 2017
ESSA Pharma Announces Pricing of Previously Announced Equity Offering
HOUSTON and VANCOUVER , Dec. 13, 2017 /CNW/ - ESSA Pharma Inc. (TSXV: EPI; NASDAQ: EPIX) ("ESSA" or the "Company") is pleased to announce today ...
December 12, 2017
Windtree Therapeutics to Participate in Corporate Access Event in San Francisco, January 8 - 10, 2018
WARRINGTON, Pa., Dec. 12, 2017 /PRNewswire/ -- Windtree Therapeutics, Inc. (WINT), a biotechnology company focused on developing aerosolized KL4 surfactant therapies for respiratory diseases, today announced that its ...
December 12, 2017
Brainsway Raises $8.5 Million From Leading Israeli Investors
Brainsway Ltd. (TASE: BRIN), a leading developer of breakthrough brain disorder treatment technology, is pleased to announce that it has completed an $8.5 million equity ...
December 12, 2017
MiMedx Announces Release Of 2018 Guidance And Shareholder Conference Call
MARIETTA, Ga., Dec. 12, 2017 /PRNewswire/ -- MiMedx Group, Inc. (MDXG), the leading biopharmaceutical company developing and marketing regenerative and therapeutic biologics utilizing human placental tissue allografts and ...
Page 72 of 117